Geert Cauwenbergh
2022
In 2022, Geert Cauwenbergh earned a total compensation of $77.4K as Former interim Principal Executive and Financial Officer at RXi Pharmaceuticals, a 33% increase compared to previous year.
Compensation breakdown
| Salary | $68,750 |
|---|---|
| Stock Awards | $8,612 |
| Total | $77,362 |
Cauwenbergh received $68.8K in salary, accounting for 89% of the total pay in 2022.
Cauwenbergh also received $8.6K in stock awards.
Rankings
In 2022, Geert Cauwenbergh's compensation ranked 5,647th out of 5,760 executives tracked by ExecPay. In other words, Cauwenbergh earned more than 2.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,647 out of 5,760 | 2nd |
Division Manufacturing | 3,082 out of 3,136 | 2nd |
Major group Chemicals And Allied Products | 1,403 out of 1,422 | 1st |
Industry group Drugs | 1,308 out of 1,323 | 1st |
Industry Pharmaceutical Preparations | 956 out of 969 | 1st |
Source: SEC filing on June 9, 2023.
Cauwenbergh's colleagues
We found two more compensation records of executives who worked with Geert Cauwenbergh at RXi Pharmaceuticals in 2022.